FUS-stabilized USP7 facilitates the bevacizumab resistance of ovarian cancer through deubiquitinating PTK2
FUS-stabilized USP7 enhanced the bevacizumab resistance of OC by deubiquitinating PTK2, providing a new idea for overcoming bevacizumab resistance in OC.
Authors
- Xiaoke Wen
- R. Li (ORCID: https://orcid.org/0000-0002-0047-5343)
- Shuo Li
- Gabriélian Ni
- Ruirong Xu
Institutions
- Wannan Medical College (CN)
- Anhui Medical University (CN)
- First Affiliated Hospital of Wannan Medical College (CN)
Publication Details
- Journal
- Journal of Gynecologic Oncology
- Published
- 2025-08-11
- DOI
- https://doi.org/10.3802/jgo.2026.37.e3
- Citations
- 2
- Primary Topic
- Ubiquitin and proteasome pathways
- Type
- article
- Field-Weighted Citation Impact
- 1.61